Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Otsuka Establishes Australian Ops | Contract Pharma

What are you searching for?

Sign in
Breaking News

Otsuka Establishes Australian Ops

Aims to bring products in areas of critical, unmet patient need

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Otsuka Pharmaceutical Co. Ltd., based in Japan, has established a presence in Australia with a new office in Sydney as part of an effort to build a larger, long-term presence in Australia and Oceania. These regions have been experiencing single-digit percentage growth in the past several years and were estimated at approximately $13 billion in 2012.

Otsuka focuses on the development of new drugs for central nervous system disorders such as schizophrenia, depression and Alzheimer’s disease, areas where patients in Australia and elsewhere need better treatments.

Otsuka Australia Pharmaceutical’s recently appointed managing director Kazushi Takemoto, said, “Otsuka is pleased and honored to be a participant in the Australian healthcare sector. We will strive to make a positive contribution with our products in areas of critical, unmet patient need. Our opening in Australia, which is Otsuka’s 27thaffiliate outside Japan, is an important milestone for Otsuka as the company continues to expand and fulfill its aim to help ease the burden of diseases on people around the globe.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics